tradingkey.logo

USANA Health Sciences Inc

USNA
查看詳細走勢圖
19.620USD
-0.070-0.36%
交易中 美東報價延遲15分鐘
358.50M總市值
21.63本益比TTM

USANA Health Sciences Inc

19.620
-0.070-0.36%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-0.36%

5天

-3.44%

1月

-0.15%

6月

-35.78%

今年開始到現在

-45.33%

1年

-41.22%

查看詳細走勢圖

TradingKey USANA Health Sciences Inc股票評分

單位: USD 更新時間: 2025-12-22

操作建議

USANA Health Sciences Inc當前公司基本面數據相對非常健康,增長潛力較大。當前估值合理,在食品與煙草行業排名68/96位。機構持股佔比非常高,近一個月多位分析師給出公司評級為。最高目標價39.00。中期看,股價處於下降通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

USANA Health Sciences Inc評分

相關信息

行業排名
68 / 96
全市場排名
372 / 4578
所屬行業
食品與煙草

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 0 分析師
--
評級
39.000
目標均價
+100.93%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

USANA Health Sciences Inc亮點

亮點風險
USANA Health Sciences, Inc. and subsidiaries is a global nutrition, personal health and wellness company that develops and manufactures science-based nutritional and personal care products. Its segments include Direct selling and Hiya direct-to-consumer. The Direct Selling segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children’s health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, and Foods. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3. Essentials/CellSentials products include USANA CellSentials and HealthPak 100.
估值高估
公司最新PE估值21.71,處於3年歷史高位
機構減倉
最新機構持股11.27M股,環比減少1.22%
PRFDX持倉
明星投資者PRFDX持倉,最新持倉6.29K股
活躍度降低
近期活躍度降低,過去20天平均換手率-0.10

USANA Health Sciences Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

USANA Health Sciences Inc簡介

USANA Health Sciences, Inc. and subsidiaries is a global nutrition, personal health and wellness company that develops and manufactures science-based nutritional and personal care products. Its segments include Direct selling and Hiya direct-to-consumer. The Direct Selling segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children’s health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, and Foods. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3. Essentials/CellSentials products include USANA CellSentials and HealthPak 100.
公司代碼USNA
公司USANA Health Sciences Inc
CEOBrown (Jim H)
網址https://www.usana.com/

常見問題

USANA Health Sciences Inc(USNA)的當前股價是多少?

USANA Health Sciences Inc(USNA)的當前股價是 19.620。

USANA Health Sciences Inc 的股票代碼是什麼?

USANA Health Sciences Inc的股票代碼是USNA。

USANA Health Sciences Inc股票的52週最高點是多少?

USANA Health Sciences Inc股票的52週最高點是38.320。

USANA Health Sciences Inc股票的52週最低點是多少?

USANA Health Sciences Inc股票的52週最低點是18.480。

USANA Health Sciences Inc的市值是多少?

USANA Health Sciences Inc的市值是358.50M。

USANA Health Sciences Inc的淨利潤是多少?

USANA Health Sciences Inc的淨利潤為42.03M。

現在USANA Health Sciences Inc(USNA)的股票是買入、持有還是賣出?

根據分析師評級,USANA Health Sciences Inc(USNA)的總體評級為--,目標價格為39.000。

USANA Health Sciences Inc(USNA)股票的每股收益(EPS TTM)是多少

USANA Health Sciences Inc(USNA)股票的每股收益(EPS TTM)是0.907。
KeyAI